Raloxifene 60mg/30tabs – Pharmacy Grade

$110.00

Raloxifene, 60 mg per tablet, 30 tablets. Pharmacy Grade, Canada.

  • Dosage: 60 mg per tablet
  • Pack: 30 oral tablets
  • Selective estrogen receptor modulator (SERM)
  • Blocks estrogen in breast tissue for gyno prevention and reversal
  • Supports bone density without estrogenic rebound

A targeted SERM for gynecomastia management during and after cycles.

×
Total:

Buy raloxifene in Canada

Raloxifene is a selective estrogen receptor modulator (SERM) that blocks estrogen activity in breast tissue while acting as an estrogen agonist in bone. This Pharmacy Grade pack contains 30 tablets at 60 mg each. You buy raloxifene in Canada when you need the most targeted SERM available for gynecomastia prevention and reversal.

Who needs raloxifene

You use raloxifene when:

  • You are developing gynecomastia symptoms (puffy or sensitive nipples, tissue growth) during a steroid cycle and want a SERM that specifically targets breast tissue.
  • You have existing gyno from a previous cycle and want to reduce it without surgery — raloxifene has clinical evidence for gynecomastia reversal.
  • You prefer raloxifene over tamoxifen (Nolvadex) because it has fewer estrogenic side effects and does not lower IGF-1.
  • You are running compounds that aromatize (testosterone, dianabol, deca) and want breast-tissue-specific estrogen blockade without crashing whole-body estrogen.
  • You want a SERM that supports bone density rather than having neutral or negative effects on bone.

NOTE: For AI-based estrogen control, see on-cycle support. Raloxifene blocks estrogen at the receptor level; aromatase inhibitors reduce estrogen production.

How raloxifene works

Raloxifene binds to estrogen receptors with tissue-selective activity. In breast tissue, it acts as an antagonist — blocking estrogen from stimulating glandular growth. In bone tissue, it acts as an agonist — supporting mineral density. This selectivity is what makes raloxifene superior to tamoxifen for gyno management: tamoxifen has partial agonist activity in some tissues, while raloxifene is cleaner in its antagonism at the breast.

Clinical studies on pubertal and steroid-induced gynecomastia show raloxifene at 60 mg/day can reduce breast tissue volume over 3-6 months. It does not lower IGF-1 levels (unlike tamoxifen), which matters when you are trying to preserve growth factor signaling during or after a cycle.

How to dose raloxifene

Goal Dose Duration
Gyno prevention on cycle 30-60 mg/day Duration of cycle
Gyno reversal (existing tissue) 60 mg/day 3-6 months
Post-cycle maintenance 30 mg/day 4-8 weeks
  • Take with or without food — bioavailability is not significantly affected.
  • Raloxifene has a 28-hour half-life, so once-daily dosing provides steady coverage.
  • For reversal protocols, consistent daily dosing for at least 3 months is needed before assessing results.
  • Can be combined with an aromatase inhibitor for dual-layer estrogen control on heavily aromatizing cycles.

Best raloxifene stacks

  • Gyno prevention on test/dbol: Raloxifene 60 mg/day for breast tissue protection, plus an AI like anastrozole for systemic estrogen management if needed.
  • Gyno reversal protocol: Raloxifene 60 mg/day for 3-6 months. Can be used standalone between cycles or during TRT.
  • PCT support: Raloxifene for residual gyno management while enclomiphene or Nolvadex handles testosterone recovery. Raloxifene does stimulate LH/FSH but is generally weaker than tamoxifen or enclomiphene for PCT.

What to expect from raloxifene

Gyno prevention effects begin immediately — receptor blockade in breast tissue is active within hours of the first dose. For reversal of existing tissue, visible reduction typically takes 6-12 weeks of consistent dosing, with full results at 3-6 months. You will not feel anything subjectively — raloxifene works silently at the receptor level.

Unlike AIs, raloxifene does not reduce circulating estrogen. Your joints, mood, and libido remain unaffected because whole-body estrogen levels stay normal. Only breast tissue sees the blockade.

What raloxifene is not

Raloxifene is not a primary PCT drug — it is weaker than tamoxifen or enclomiphene at stimulating LH and FSH. It is not a replacement for aromatase inhibitors when you need to lower total estrogen. It does not guarantee gyno reversal in all cases — long-standing, calcified tissue may require surgical consultation. It has no anabolic properties.

Order and delivery

We ship raloxifene across Canada from domestic stock. Pharmacy Grade product with full traceability. Discreet packaging, tracked shipping, and shelf-stable tablets.

Pharmacy Grade Raloxifene FAQ

Is raloxifene better than Nolvadex for gyno?

For gynecomastia specifically, yes. Raloxifene has cleaner breast-tissue antagonism, does not lower IGF-1, and has clinical trial data showing gyno reduction. Nolvadex is stronger for PCT testosterone recovery but has partial agonist activity that makes it less ideal for gyno reversal.

Can I use raloxifene and an AI together?

Yes. They work through different mechanisms — raloxifene blocks estrogen at the receptor, while AIs reduce estrogen production. Together they provide dual-layer protection on heavily aromatizing cycles. Monitor estrogen levels to avoid crashing E2.

How long does it take to reverse gyno with raloxifene?

Most users see noticeable reduction at 6-12 weeks, with continued improvement through 3-6 months. Early-stage gyno (soft, recently developed) responds better than old, fibrotic tissue. Consistent daily dosing is essential.

Why buy raloxifene at Roids101 in Canada?

We stock genuine Pharmacy Grade raloxifene with domestic Canadian shipping. No customs risk, tracked delivery, and a support team that understands how SERMs fit into cycle management and gyno protocols.

Reviews

There are no reviews yet

Be the first to review “Raloxifene 60mg/30tabs – Pharmacy Grade”

Your email address will not be published. Required fields are marked *